Learn about the feasibility and effectiveness of administering medication-assisted treatment for opioid use disorder (OUD) within a Twelve Step treatment program. Hazelden Betty Ford’s chief medical officer, Marvin D. Seppala, MD, will describe the treatment center’s evidence-based protocols targeting OUD and discuss results of a six-month outcomes study showing dramatic improvements in treatment retention, engagement and continuous abstinence rates.
Under Dr. Seppala’s leadership, Hazelden Betty Ford developed Comprehensive Opioid Response with the Twelve Steps (COR-12), an innovative treatment protocol targeting opioid use disorder. The approach combines evidence-based practices including Twelve Step Facilitation therapy, psychotherapies for substance use disorders, and medications in pursuit of better treatment outcomes for patients with OUD.
Can't attend on the scheduled date?
Register and you'll receive notice when we post the recording for on-demand viewing.
A certificate of completion will be awarded for attending this event. Please note, this event has not been approved for continuing education (CE) credit. The participant is responsible to verify if this activity meets their continuing education board requirements in order to gain credit.
Questions? Contact Ann Tucker.